Department of Pediatric Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Pediatr Blood Cancer. 2010 Apr;54(4):546-51. doi: 10.1002/pbc.22286.
Totally implantable access ports (TIAPs) are widely used in pediatric hematology-oncology patients. We investigated the incidence of complications, causes of TIAP removal, and risk factors for infection.
We retrospectively analyzed the clinical, demographic, and surgical characteristics in 225 pediatric hematology-oncology patients implanted with 238 TIAPs between January 2004 and December 2005.
Except for 20 patients lost to follow-up, the mean maintenance period was 724.8 +/- 500.6 days (range: 17-2,124). Mechanical complications occurred in seven patients (2.9%). The causes of TIAP removal were termination of use in 130 patients (59.6%), death from primary disease with TIAP in situ in 35 (14.7%), infection in 35 (14.7%), and obstruction in 4 (1.8%). Early infections occurred in nine patients at mean 37.77 +/- 16.44 days (range: 17-56). Late infections occurred in 26 patients at mean 334.5 +/- 257.82 days (range: 68-997). Univariate analysis showed that the risk factors of early infection were re-implantation (P = 0.022) and long operation time (P = 0.045). The risk factors of late infection were ANC <500/mm(3) (P = 0.011) and platelet count <50,000/mm(3) (P < 0.001). In multivariate analysis, re-implantation was a significant risk factor of early infection (P = 0.033, OR 4.528) and low platelet count (<50,000/mm(3)) was the independent risk factor for late infection (P = 0.005, OR 4.24).
Correct procedure and careful use decreases the incidence of early infection and leads to the prevention of re-implantation. Initial thrombocytopenia was attributable to bone marrow suppression caused by hematologic malignancies or severe infection. Thus, this condition is of value in predicting late infection.
完全植入式输液港(TIAPs)在儿科血液肿瘤患者中广泛应用。我们研究了并发症的发生率、TIAP 移除的原因和感染的危险因素。
我们回顾性分析了 2004 年 1 月至 2005 年 12 月期间 225 例儿科血液肿瘤患者的临床、人口统计学和手术特征,这些患者共植入 238 个 TIAP。
除 20 例失访患者外,平均随访时间为 724.8±500.6 天(范围:17-2124 天)。7 例患者发生机械并发症(2.9%)。TIAP 移除的原因包括 130 例患者(59.6%)终止使用、35 例(14.7%)原发疾病死亡伴 TIAP 原位、35 例(14.7%)感染和 4 例(1.8%)梗阻。9 例患者在平均 37.77±16.44 天(范围:17-56 天)时发生早期感染。26 例患者在平均 334.5±257.82 天(范围:68-997 天)时发生晚期感染。单因素分析显示,早期感染的危险因素是再植入(P=0.022)和手术时间长(P=0.045)。晚期感染的危险因素是 ANC<500/mm³(P=0.011)和血小板计数<50,000/mm³(P<0.001)。多因素分析显示,再植入是早期感染的显著危险因素(P=0.033,OR 4.528),血小板计数低(<50,000/mm³)是晚期感染的独立危险因素(P=0.005,OR 4.24)。
正确的操作和小心使用可降低早期感染的发生率,并可预防再次植入。初始血小板减少症归因于血液恶性肿瘤或严重感染引起的骨髓抑制。因此,这种情况对于预测晚期感染具有重要价值。